- Posted on 21 December, 2017, by Felix Jansson
- Posted on 13 December, 2017, by Felix Jansson
- Posted on 13 December, 2017, by Felix JanssonRead more
We are today launching a brand new version of Monocl EGO! We have created a whole new interface, built new modules and added hundreds of new features to truly transform your workflow and drive operational efficiency. We want you to be at least one step ahead of your competition – every single time.
- Posted on 11 December, 2017, by Felix JanssonRead more
We are incredibly excited about what we have in store for you this week. We are now in the process of making the final touches on our greatest update since launch – a new version of Monocl EGO. To celebrate, we are handing out two annual subscriptions of the new Monocl EGO. Register for the Christmas Raffle to win a subscription!
- Posted on 5 December, 2017, by Felix JanssonRead more
The competition to work with opinion leaders, and increasingly with emerging rising stars is extremely fierce. Therefore, it is important to establish strong relationships with the right opinion leaders as early as possible. But identifying and prioritizing which stakeholders to collaborate with is challenging. Join our webinar on December 15th where we will share our experience and insights on the matter at hand.
- Posted on 27 October, 2017, by Felix JanssonRead more
Today, we are making millions of news articles, corporate press releases, blog posts, conferences, scientific forums and much more readily accessible on all the expert profiles in Monocl EGO.
- Posted on 20 October, 2017, by Felix JanssonRead more
Externalization has been a frequently discussed topic and increasingly employed R&D strategy within Life Science for the last decade, but only 25% of companies have a clear strategy on how they will approach externalization. Here we try to shed light on the constituent parts that make up an external R&D strategy and the tools you should be using.
- Posted on 2 October, 2017, by Felix Jansson
Aligning interests between CROs and Pharma – how to get more out of site feasibility and investigator selectionRead more
The early process of selecting sites and investigators for a clinical study is one of the most critical tasks in running trials, as it forms the foundation for successful recruitment rates. However, the process often lacks transparency and alignment of interests between the parties involved, creating a non-optimal outcome and by extension jeopardizes the success of the trial. We share our perspective on issue…
- Posted on 15 September, 2017, by Björn Carlsson
- Posted on 19 July, 2017, by Björn CarlssonRead more
12 million new payments with a combined dollar value of 8.2 billion have been added to Monocl EGO. These payments are based on the 2016 data set from CMS Open Payments and they have been integrated using our powerful machine learning framework. Monocl EGO now lets you evaluate financial transactions between companies and physicians based on more than 40 million payments. The combined value…
- Posted on 28 June, 2017, by Felix Jansson
- Posted on 5 June, 2017, by Felix JanssonRead more
Anyone who has worked in the industry knows that identifying and selecting the right site and investigators is of paramount importance to the success of your pipeline and to keep costs down. But, getting access to and analyzing the information you need to make an unbiased, well-informed decision is troublesome and time-consuming. Learn how you can combine and analyze multiple data sources to uncover…
- Posted on 26 April, 2017, by Felix JanssonRead more
Are you attending ASCO Annual Meeting 2017 on June 2-6 in Chicago? Learn how we are helping our customers to improve their conference planning process.
- Posted on 19 April, 2017, by Felix JanssonRead more
It is difficult for sales and marketing professionals to know which leads and prospects that are the most likely to buy products and services. Not every single prospect walks around with a sign above their head that tells you they have cash available to invest in your products – until now. Learn how you can use grants data to sell more and sell smarter...
- Posted on 6 April, 2017, by Felix JanssonRead more
We are working with a range of great companies. Although inherently different, they all ask us for a better way to track and monitor academic and corporate funding activities to improve their decision making. We will post a series of blog posts covering why academic and corporate funding activities are important and how you can use that data to make smarter decisions.
Monocl enables life science professionals work smarter with the right external stakeholders. We have developed Monocl EGO, a cloud-based platform designed to help you collaborate and compete smarter. Monocl EGO lets you find and engage with the right stakeholders, regardless if you are looking for scientific experts, investigators, medical institutions, customers or competitors. The platform contains millions of scientific experts and organizations, each seamlessly profiled to help you understand collaborations, research activities and financial transactions in a superior manner. Monocl EGO is empowered by a machine-learning architecture currently based on source data from research publications, clinical trials, grant funding, industry payments and more.